Protective effect of necrostatin-1 on the liver of rats with trauma induced hemorrhagic shock

Chinese Critical Care Medicine

Volumn 26, Issue 1, 2014, Pages 17-22

  Liya, Zhang ^a   Cui, Yaoli ^a   Wang, Bing ^a   Yu, Jinbao ^a   Wang, Liniin ^a   Wang, Yuliang ^a   Wang, Yongqiang ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN FIRST CENTRAL HOSPITAL   (China)

Author keywords

Hemorrhagic shock; Ischemia reperfusion injury; Liver injury; Necrostatin 1; Trauma

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARRIER PROTEINS AND BINDING PROTEINS; INTERLEUKIN 1BETA; LIVER PROTECTIVE AGENT; NECROSTATIN 1; RECEPTOR INTERACTION PROTEIN 1; RECEPTOR INTERACTION PROTEIN 3; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; EXPERIMENTAL LIGATION; FEMUR; GENE EXPRESSION REGULATION; HEMORRHAGIC SHOCK; HISTOPATHOLOGY; LIVER INJURY; LIVER LEVEL; LIVER PROTECTION; MALE; MORTALITY; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SOFT TISSUE INJURY; SPRAGUE DAWLEY RAT; TIBIA FRACTURE; UPREGULATION;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; DISEASE MODELS, ANIMAL; IMIDAZOLES; INDOLES; LIVER; MALE; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SHOCK, HEMORRHAGIC; SHOCK, TRAUMATIC;

EID: 84895856334     PISSN: 20954352     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.2095-4352.2014.01.004     Document Type: Article

References (18)

1. Kroemer G,Martin SJ. Caspase-independent cell death [J]. Nat Med,2005,11(7): 725-730.
2. Degterev A, Huang Z, Boyce M, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury [J]. Nat Chem Biol, 2005, ( ( 2 ) : 112-119.
3. Christofferson DE,Yuan J. Necroptosis as an alternative form of programmed cell death [J]. Curr Opin Cell Biol,2010,22 (2): 263-268.
4. Cho YS, Challa S, Moquin D, et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation[J]. Cell, 2009, 137(6): 1112-1123.
5. Zhang DW, Shao J, Lin J, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosi[[J]. Science,2009,325(5938) : 332-336.
6. Zaets SB, Xu DZ, Lu Q, et al. Recombinant factor M mitigates hemorrhagic shock-induced organ dysfunction [J]. J Surg Res, 2011,166(2): e135-142. 2011,18(2):82-85.
7. Alam HB, Stanton K, Koustova E, et al. Effect of different resuscitation strategies on neutrophil activation in a swine model of hemorrhagic shock[J]. Resuscitation,2004,60( 1 ) : 91-99.
8. Dinarello CA. Proinflammatory cytokines [J ]. Chest, 2000,118(2); 503-508.
9. Degterev A,Hitomi J,Germscheid M,et al. Identification of RIP1 kinase as a specific cellular target of necrostatins [J]. Nat Chem Biol,2008,4(5): 313-321.
10. He S,Wang L,Miao L,et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha[J]. Cell, 2009, 137(6): 1100-1111.
11. Declercq W,Vanden Berghe T,Vandenabeele P. RIP kinases at the crossroads of cell death and survival [J]. Cell,2009, 138 (2) ; 229-232.
12. Han W,Xie J,Li L,et al. Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis[J]. Apoptosis,2009, 14(5) : 674-686.
13. Xu X,Chua CC,Kong J,et al. Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells[J]. J Neurochem,2007, 103 (5) : 2004-2014.
14. You Z, Savitz SI, Yang J, et al. Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice[J]. J Cereb Blood Flow Metab,2008,28(9): 1564-1573.
15. Oerlemans MI,Liu J,Arslan F,et al. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo[J]. Basic Res Cardiol,2012,107(4) : 270.
16. Smith CC, Davidson SM, Lim SY, et al. Necrostatin: a potentially novel cardioprotective agent? [J]. Cardiovasc Drugs Ther,2007,21 (4): 227-233.
17. Northington FJ,Chavez-Valdez R,Graham EM,et al. Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI[J]. J Cereb Blood Flow Metab,2011,3(( 1 ) : 178-189.
18. Xu X,Chua KW,Chua CC,et al. Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury[J]. Brain Res, 2010,1355: 189-194.